Insights from 2024 ATS Annual Meeting
Playback speed
10 seconds
ATS 2024 Insights: Interim Results From the Phase 1B and Phase 2 TORREY Open-Label Extension Study of Seralutinib in PAH
By
Insights from 2024 ATS Annual Meeting
FEATURING
Olivier Sitbon
By
Insights from 2024 ATS Annual Meeting
FEATURING
Olivier Sitbon
269 views
June 18, 2024
Comments 0
Login to view comments.
Click here to Login
Videos